• 4 February 2011
  • News
  • By

PPP: A push for affordable healthcare

In the second part of this series that decodes the success of PPPs and its prospects, BioSpectrum showcases three case studies that exemplify the benefits of such partnerships

Development of innovative technologies to facilitate research in 3D Cell Culture for Regenerative Medicine and Tissue Engineering by Hyderabad-based ExCel Matrix Biological Devices.

Bhubneshwar-based Imgenex India's initiatives on developing drugs against osteoporosis using the applications of nanobiotechnology.

New Delhi-based ARA Healthcare's projects to carry out pre-clinical and phase I clinical development of three recombinant proteins, ARA-I, ARA-II, and ARA-III.

Mission: Creating novel tissue engineering techniques

Mission: Tackling osteoporosis using nanobiotech

Mission: Fighting cancer with recombinant

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

Union Budget

Has Union budget 2017 addressed all requirements of healthcare industry?

Send this article by email